PRIVISCL — Privi Speciality Chemicals Balance Sheet
0.000.00%
- IN₹122.74bn
- IN₹133.17bn
- IN₹21.01bn
Annual balance sheet for Privi Speciality Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 278 | 626 | 318 | 635 | 573 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,938 | 3,384 | 3,469 | 3,840 | 4,722 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,002 | 10,526 | 12,023 | 11,418 | 13,633 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,652 | 10,619 | 11,007 | 11,132 | 12,728 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 15,402 | 21,760 | 23,911 | 23,425 | 27,905 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,536 | 9,289 | 11,013 | 8,960 | 11,034 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,177 | 13,638 | 15,620 | 14,182 | 16,871 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7,225 | 8,123 | 8,291 | 9,244 | 11,034 |
| Total Liabilities & Shareholders' Equity | 15,402 | 21,760 | 23,911 | 23,425 | 27,905 |
| Total Common Shares Outstanding |